Responses
Regular and Young Investigator Award Abstracts
Immuno-Conjugates and Chimeric Molecules
1197 Site-specific anti-PD-1-iRGD peptide conjugate boosts antitumor efficacy via enhancement of T cell penetration and engagement
Compose a Response to This Article
Other responses
No responses have been published for this article.
